The dual role of RNA-binding proteins: promotion of tumorigenesis, drug resistance, and emerging therapeutic targets
Acta Biochimica et Biophysica Sinica · 01.12.2025 · 57 (12) · 1923-1938
DOI: 10.3724/abbs.2025099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 12.08.2025. Verfasst von Zemei Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Shanwei 516600, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cancer is a complex and multifaceted disease characterized by a multitude of molecular factors. RNA-binding proteins (RBPs) have emerged as pivotal regulators of tumor development, progression, and chemoresistance through their interactions with target transcripts. These interactions regulate a multitude of processes, including alternative splicing, cleavage and polyadenylation, RNA localization, translation, N6-methyladenosine (m6A) RNA modification, and DNA double-strand break repair. The RBP family comprises over 2000 proteins and plays a critical role in oncogene expression, invasion, metastasis, and inhibition of apoptosis. However, the mechanisms by which RBPs selectively recognize RNAs remain an active area of research. This review examines recent advancements in understanding RNA-binding domains and the RNA processes regulated by RBPs in tumorigenesis. Notably, this study summarizes and highlights the roles of RNA-binding domains in cancers and the molecular mechanisms of RBPs in chemotherapy resistance. It also discusses the potential of targeting RBPs for cancer therapy and reviews RBPs that are dysregulated in cancers. Additionally, we highlight recently developed tools for predicting RBP-RNA binding activities to provide valuable support for ongoing research efforts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Shanwei 516600, China.
- Shantou Key Laboratory of Precision Diagnosis and Treatment in Women's Cancer Shantou University Medical College Cancer Hospital, Shantou 515041, China.
Zitieren
APA
Xu, Z., & Cui, Y. (2025). The dual role of RNA-binding proteins: promotion of tumorigenesis, drug resistance, and emerging therapeutic targets. Acta Biochimica et Biophysica Sinica, 57(12), 1923-1938. https://doi.org/10.3724/abbs.2025099
Vancouver
Xu Z, Cui Y. The dual role of RNA-binding proteins: promotion of tumorigenesis, drug resistance, and emerging therapeutic targets. Acta Biochimica et Biophysica Sinica. 2025;57(12):1923-1938. doi:10.3724/abbs.2025099
BibTeX
@article{Xu2025,
author = {Xu, Zemei and Cui, Yukun},
title = {The dual role of RNA-binding proteins: promotion of tumorigenesis, drug resistance, and emerging therapeutic targets},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2025},
volume = {57},
number = {12},
pages = {1923--1938},
doi = {10.3724/abbs.2025099}
}
EUVIMED